LIFECORE BIOMEDICAL INC

LifeCore Biomedical Inc. is a privately held supplier of biologic materials and ancillary services devised for cell therapy, regenerative medicine, and pharmaceutical manufacturing partners, delivering GMP-grade human serum alternatives, ISO-certified cryopreservation media, and traceable donor-derived proteins that feed discovery-to-commercialization pipelines; the firm’s profile sits amid the Pharmaceutical Preparations/Biological Products SIC constellation, and its offerings aim to serve biopharma developers, academic translational labs, and contract manufacturers that depend on consistent, contamination-free reagents. LifeCore must navigate FDA, DEA, and state-level oversight around blood-derived products, maintain rigorous quality systems and supply chain traceability, and absorb risks tied to global raw material volatility plus evolving clinical trial standards; the latest SEC filing details remain unavailable right now, yet investors can keep tabs on regulatory disclosures and material updates associated with CIK 28626. For the freshest insights, check live SEC filings on Earnings Feed.

Source: Earnings Feed research · last updated 11/24/2025